Study of the effect of anagliptin on glucose and lipid metabolism abnormality after the test meal loading.
Not Applicable
- Conditions
- Impaired glucose tolerance. Type II diabetes mellitus.
- Registration Number
- JPRN-UMIN000011424
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who used DPP-4 inhibitors within the last 3 months. 2. Patients with contraindication of anagliptin following: Patients who have a history of allergy due to anagliptin. Severe ketosis, diabetic coma or precoma, type I diabetes mellitus. Severe infection, before and after surgery, patients with severe trauma. 3. Patients on insulin. 4. Patients on rapid-acting insulin secretagogue. 5. Patients with severe renal failure and/or dialysis. 6. Patients with food allergy due to test meal component. 7. Patients who were judged to be inappropriate for the study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method